Biomedical Engineering Reference
In-Depth Information
AOKI J, SERRUYS PW, VAN BEUSEKOM H, ONG ATL, MCFADDEN EP, SIANOS G, VAN DER
GIESSEN WJ, REGAR E, DE FEYTER PJ, DAVIS HR, ROWLAND S and KUTRYK MJB. Endo-
thelial progenitor cell capture by stents coated with antibody against CD34. The
HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal
Growth-First In Man) Registry.
J Am Coll Cardiol
2005;
45
: 1574-1579.
ARONSON D. Potential role of advanced glycosylation end products in promoting
restenosis in diabetes and renal failure.
Med Hypotheses
2002;
59
: 297-301.
BARTORELLI AL, TRABATTONI D, MONTORSI P, FABBIOCCHI F, GALLI S, RAVAGNANI P,
GRANCINI L, COZZI S and LOALDI A. Aspirin alone antiplatelet regimen after intra-
coronary placement of the carbostent: The ANTARESstudy.
Cathet Cardiovasc
Interven
2002;
55
: 150-156.
BAVRY AA, KUMBHANI DJ, HELTON TJ, BOREK PP, MOOD GR and BHATT DL. Late thrombosis
of drug eluting stents.
Am J Med
2006;
119
: 1056-1061.
BAZIAN LTD. Drug-eluting stents have yet to prove their worth.
Evidence Based
Healthcare and Public Health
2005;
9
: 101-103.
BEAUDRY Y, SZE S, FAGIH B, CONSTANCE C and KWEE R. Six-month results of small vessel
stenting (2.0-2.8 mm) with the Biodivysio SV stent.
J Invasive Cardiol
2001;
13
(9):
628-631.
BERGER-GARBET M, BROXUP B, RIVARD CH and YAHIA LH. Biocompatibility testing of
NiTi screws using immunohistoctochemistry on sections containing metallic
implants.
J Biomedi Mater Res
1996;
30
: 243-248.
BERTRAND O F and SIPEHIA R. Biocompatibility aspects of new stent technology.
J Am
Coll Cardiol
1998;
32
: 562-567.
BHARGAVA B, DE SCHEERDER I, PING QB, YANMING H, CHAN R, KIM HS, KOLLUM M, COTTIN
Y and LEON MB. A novel platinum-iridium, potentially gamma radioactive stent:
evaluation in a porcine model.
Cathet Cardiovasc Intervent
2000;
51
: 364-368.
BONAN R and ASGAR AW. Biodegradable stents - where are we in 2009?
Interventional
Cardiol
2009; 81-84.
BREN L, ENGLISH L, FOGARTY J, POLICORO R, ZSIDI A, VANCE J, RELICH J, WHITE C, DONAHUE
S, ISTEPHANOUS N and ROHLY K. Effect of surface characteristics of metallic bioma-
terials on interaction with osteoblast cells. 7th World Biomaterials Congress, 2004;
1121.
BRITISH HEART FOUNDATION STATISTICS DATABASE 2008. www.heartstats.org.
BYRNE RA, MEHILLI J, IIJIMA R, SCHULZ S, PACHE J, SEYFARTH M, SCHÖMIG A, KASTRATI A
for the Intracoronary Stenting and Angiographic Results: Test Effi cacy of 3
Limus-Eluting STents (ISAR-TEST-2). A polymer-free dual drug-eluting stent in
patients with coronary artery disease: a randomized trial vs. polymer-based drug-
eluting stents.
Eur Heart J
2009;
30
(8): 923-931.
CHILTON JP.
Principles of Metallic Corrosion
, 2nd edition. London: Royal Institute
of Chemistry, 1968.
COLOMBO A & TAKAGI T. The Carbostent SIRIUS stent. In: P. W. Serruys,
Handbook
of Coronary Stents
. Benno Rensing, 2001.
COLOMBO A, ITOH A and MARIO CD. Sucessful closure of a coronary vessel rupture with
a vein graft stent: case report.
Cathet Cardiovasc Diagn
1996;
38
: 172-174.
COSTA JR JR, ABIZAID A, COSTA R, FERES F, TANAJURA LF, ABIZAID A, MALDONADO G,
STAICO R, SIQUEIRA D, SOUSA AG, BONAN R and SOUSA JE. 1-year results of the
hydroxyapatite polymer-free sirolimus-eluting stent for the treatment of single de
novo coronary lesions: the VESTASYNC 1 trial.
JACC Cardiovasc Interv
2009;
2
(5): 422-427.
Search WWH ::
Custom Search